FDA product code DXE: Catheter, Embolectomy
DXE is the FDA product code for catheter, embolectomy. It is a Class II device, regulated under 21 CFR 870.5150 and reviewed by the Cardiovascular panel. FDA has cleared 74 510(k) submissions under DXE, 6 in the last five years, from 41 different applicants. The average 510(k) review took 148 days (median 134); 164 days on average over the last three years. FDA has posted 58 recalls for DXE devices, 8 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | Catheter, Embolectomy |
| Device class | Class II |
| Regulation | 21 CFR 870.5150 |
| Review panel | CV — Cardiovascular |
| Medical specialty | Cardiovascular |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for DXE
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 2 | 246 |
| 2020 | 1 | 190 |
| 2021 | 1 | 410 |
| 2022 | 1 | 56 |
| 2024 | 5 | 164 |
Compare with all 510(k) review times · Search every DXE clearance
Top DXE applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Shiley, Inc. | 5 | 1989-10-12 |
| Vascutech, Inc. | 4 | 2000-03-08 |
| Lucas Medical, Inc. | 4 | 1997-11-19 |
| Ideas For Medicine, Inc. | 4 | 1997-01-13 |
| Cathlab Corp. | 4 | 1991-02-25 |
36 more applicants have DXE clearances. See the full list in Caduvo.
Most recent DXE clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K240078 | Edwards Lifesciences, LLC | Fogarty Thru-Lumen Embolectomy Catheter | 2024-08-28 | 230 |
| K241330 | Edwards Lifesciences | Fogarty Fortis Arterial Embolectomy Catheter | 2024-07-02 | 53 |
| K233819 | Edwards Lifesciences, LLC | Fogarty Venous Thrombectomy Catheters | 2024-05-22 | 173 |
| K233820 | Edwards Lifesciences | Fogarty Arterial Embolectomy Catheter with Gate Valve | 2024-05-22 | 173 |
| K233619 | Edwards Lifesciences | Fogarty Corkscrew Catheters; Fogarty Graft Thrombectomy Catheters | 2024-05-20 | 189 |
Recalls for DXE devices
58 product recalls in 31 recall events; 8 initiated in the last five years and 9 still open. Most recent: 2026-08-28.
| Year | Recalls |
|---|---|
| 2017 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Frequently asked questions
What is FDA product code DXE?
DXE is the FDA product code for catheter, embolectomy. It is a Class II device, regulated under 21 CFR 870.5150 and reviewed by the Cardiovascular panel.
What device class is DXE?
Class II, regulation 21 CFR 870.5150. Typical premarket route: 510(k).
How long does a 510(k) take for product code DXE?
Across 74 cleared submissions the average was 148 days from receipt to decision (median 134).
Which companies have the most DXE clearances?
Shiley, Inc. (5); Vascutech, Inc. (4); Lucas Medical, Inc. (4); Ideas For Medicine, Inc. (4); Cathlab Corp. (4).
Have DXE devices been recalled?
Yes: 58 product recalls across 31 recall events; the most recent began 2026-08-28.
Next steps
- Run an FDA pathway report with predicate devices for product code DXE
- Run a recall and safety report across every DXE manufacturer
- Watch product code DXE for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times